Analyst Ratings for Oncothyreon (ONTY)
ONTY Rating Summary
ONTY Price Target Summary
- Highest: $14.00 (JMP Securities)
- Lowest: $1.00 (Piper Jaffray)
- Average: $7.25
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.25 (+264.3%)
Avg. $ Target:
$7.25 (+264.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/17/2013 | Wedbush | Upgrade | Outperform (Neutral) |
N/A (N/A) |
1.97 | 1.99 | 1.02% | Details |
| 1/17/2013 | Piper Jaffray | New Coverage | Underweight (N/A) |
1.00 (N/A) |
2.27 | 1.99 | -12.33% | Details |
| 8/24/2012 | Stifel Nicolaus | New Coverage | Buy (N/A) |
10.00 (N/A) |
4.37 | 1.99 | -54.46% | Details |
| 5/23/2012 | WBB Securities | Upgrade | Hold (N/A) |
N/A (N/A) |
3.66 | 1.99 | -45.63% | Details |
| 1/25/2012 | Cantor Fitzgerald » Updated 3/15/2013 |
New Coverage | Buy (N/A) |
4.00 (11.00) |
6.32 | 1.99 | -68.51% | Details |
| 5/31/2011 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.43 | 1.99 | -69.05% | Details |
| 4/25/2011 | Rodman & Renshaw | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
4.47 | 1.99 | -55.48% | Details |
| 8/13/2010 | JMP Securities » Updated 1/24/2012 |
New Coverage | Market Outperform (N/A) |
14.00 (N/A) |
3.53 | 1.99 | -43.63% | Details |
